Healthy humans, healthy animals and a healthy environment - the One Health approach does not look at these individually, instead it considers them as a whole. A new alliance led by the University of Greifswald now wants...
The eHealth system SORMAS (abbreviation for “Surveillance Outbreak Response Management and Analysis System”) was developed in the Department of Epidemiology at the Helmholtz Centre for Infection Research (HZI) in...
A team of researchers led by Anca Dorhoi at the Friedrich-Loeffler-Institut (FLI) and Emmanuel Saliba at the Helmholtz Institute for RNA-based Infection Research (HIRI), has elucidated age-dependent variations in...
Birch pollen is not only a nuisance for allergy sufferers. They can also affect the cells of the innate immune system and make them more susceptible to viral infections. This was now shown by a team of researchers at...
The development of effective agents against viral pathogens is of increasing importance for global health. In particular, there is an urgent need for innovative therapeutic options for viral diseases for which no...
Although there are many female virologists, microbiologists, and infectious diseases researchers in leadership positions at German universities and research institutes, they are usually not in the public eye. The...
The endogenous molecule itaconic acid has antiviral and anti-inflammatory effects, as researchers from TWINCORE have recently shown. In cooperation with scientists from the Helmholtz Centre for Infection Research in...
The LOKI pilot project was launched on 1 July 2022 under the leadership of the Helmholtz Centre for Infection Research (HZI) and in collaboration with the Academy for Public Health Services (AÖGW), the CISPA Helmholtz...
Hepatitis D is by far the most severe form of chronic viral hepatitis frequently leading to liver failure, hepatocellular carcinoma and death. However, there is very limited knowledge on disease pathophysiology and...
